Identification of lipid A deacylase as a novel, highly conserved and protective antigen against enterohemorrhagic Escherichia coli
暂无分享,去创建一个
F. Polticelli | M. Desvaux | M. Pizza | M. Soriani | R. Rosini | M. Rojas-Lopez | M. Martinelli | Grégory Jubelin | Valentina Brandi | Maricarmen Rojas-Lopez
[1] C. Buonsanti,et al. Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota. , 2019, Vaccine.
[2] J. Dokmetjian,et al. OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves , 2018, Human vaccines & immunotherapeutics.
[3] M. Desvaux,et al. Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development , 2018, Front. Microbiol..
[4] T. Tobe,et al. Activation of lpxR gene through enterohaemorrhagic Escherichia coli virulence regulators mediates lipid A modification to attenuate innate immune response , 2018, Cellular microbiology.
[5] F. Necchi,et al. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella. , 2017, Vaccine.
[6] Henrik Nielsen,et al. Predicting Secretory Proteins with SignalP. , 2017, Methods in molecular biology.
[7] S. Beatson,et al. A Novel Protective Vaccine Antigen from the Core Escherichia coli Genome , 2016, mSphere.
[8] Laura A. Muruato,et al. From In silico Protein Epitope Density Prediction to Testing Escherichia coli O157:H7 Vaccine Candidates in a Murine Model of Colonization , 2016, Front. Cell. Infect. Microbiol..
[9] I. Henderson,et al. A secretome view of colonisation factors in Shiga toxin-encoding Escherichia coli (STEC): from enterohaemorrhagic E. coli (EHEC) to related enteropathotypes. , 2016, FEMS microbiology letters.
[10] F. Necchi,et al. Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis , 2016, Clinical and Vaccine Immunology.
[11] I. Chinen,et al. Enterohemorrhagic (Shiga Toxin-Producing) Escherichia coli , 2016 .
[12] A. Colucci,et al. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB , 2015, PloS one.
[13] M. Kaparakis-Liaskos,et al. Immune modulation by bacterial outer membrane vesicles , 2015, Nature Reviews Immunology.
[14] A. Kalita,et al. Exploiting the power of OMICS approaches to produce E. coli O157 vaccines , 2014, Gut microbes.
[15] L. Maggiore,et al. Comparison of Colorimetric Assays with Quantitative Amino Acid Analysis for Protein Quantification of Generalized Modules for Membrane Antigens (GMMA) , 2014, Molecular Biotechnology.
[16] C. MacLennan,et al. Vaccines against poverty , 2014, Proceedings of the National Academy of Sciences.
[17] R. Rappuoli,et al. Vaccines, new opportunities for a new society , 2014, Proceedings of the National Academy of Sciences.
[18] C. Leclerc,et al. Decoration of Outer Membrane Vesicles with Multiple Antigens by Using an Autotransporter Approach , 2014, Applied and Environmental Microbiology.
[19] G. Bensi,et al. SslE Elicits Functional Antibodies That Impair In Vitro Mucinase Activity and In Vivo Colonization by Both Intestinal and Extraintestinal Escherichia coli Strains , 2014, PLoS pathogens.
[20] Marco Biasini,et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information , 2014, Nucleic Acids Res..
[21] A. Torres,et al. A Burkholderia pseudomallei Outer Membrane Vesicle Vaccine Provides Protection against Lethal Sepsis , 2014, Clinical and Vaccine Immunology.
[22] A. Kalita,et al. Comparative Genomics and Immunoinformatics Approach for the Identification of Vaccine Candidates for Enterohemorrhagic Escherichia coli O157:H7 , 2014, Infection and Immunity.
[23] O. Jousson,et al. Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen , 2014, Journal of extracellular vesicles.
[24] L. Morici,et al. Evaluation of a Burkholderia pseudomallei Outer Membrane Vesicle Vaccine in Nonhuman Primates , 2014, Procedia in vaccinology.
[25] Anne M. Stringer,et al. Identification of HilD-Regulated Genes in Salmonella enterica Serovar Typhimurium , 2013, Journal of bacteriology.
[26] D. Keim,et al. Comparison of strand-specific transcriptomes of enterohemorrhagic Escherichia coli O157:H7 EDL933 (EHEC) under eleven different environmental conditions including radish sprouts and cattle feces , 2014, BMC Genomics.
[27] B. Finlay,et al. Recent Advances in Understanding Enteric Pathogenic Escherichia coli , 2013, Clinical Microbiology Reviews.
[28] A. Kalita,et al. Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection. , 2013, Vaccine.
[29] Sebastian Kelm,et al. Memoir: template-based structure prediction for membrane proteins , 2013, Nucleic Acids Res..
[30] A. Pierleoni,et al. Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro , 2013, Journal of extracellular vesicles.
[31] K. Kawasaki,et al. Lipid A 3'-O-deacylation by Salmonella outer membrane enzyme LpxR modulates the ability of lipid A to stimulate Toll-like receptor 4. , 2012, Biochemical and biophysical research communications.
[32] V. Sperandio,et al. Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies , 2012, Front. Cell. Inf. Microbio..
[33] L. Maggiore,et al. High Yield Production Process for Shigella Outer Membrane Particles , 2012, PloS one.
[34] R. Rappuoli,et al. Escherichia coli: Great Diversity around a Common Core , 2012, mBio.
[35] Shane S. Sturrock,et al. Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data , 2012, Bioinform..
[36] P. Goldwater,et al. Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS) , 2012, BMC Medicine.
[37] A. O’Brien,et al. Mouse Models of Escherichia coli O157:H7 Infection and Shiga Toxin Injection , 2011, Journal of biomedicine & biotechnology.
[38] Martin Ester,et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes , 2010, Bioinform..
[39] Rino Rappuoli,et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli , 2010, Proceedings of the National Academy of Sciences.
[40] Yang Zhang,et al. I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.
[41] M. Kuehn,et al. Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles , 2010, Microbiology and Molecular Biology Reviews.
[42] B. Finlay,et al. Molecular mechanisms of Escherichia coli pathogenicity , 2012, Nature Reviews Microbiology.
[43] Pascal Benkert,et al. QMEAN server for protein model quality estimation , 2009, Nucleic Acids Res..
[44] Alexandre M J J Bonvin,et al. Active-site architecture and catalytic mechanism of the lipid A deacylase LpxR of Salmonella typhimurium , 2009, Proceedings of the National Academy of Sciences.
[45] Scott A Lesley,et al. The Polymerase Incomplete Primer Extension (PIPE) method applied to high-throughput cloning and site-directed mutagenesis. , 2009, Methods in molecular biology.
[46] Claudio Donati,et al. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. , 2006, Current opinion in microbiology.
[47] H. Tettelin,et al. Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen , 2005, Science.
[48] P. Tarr,et al. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome , 2005, The Lancet.
[49] R. Rappuoli,et al. The concept of "tailor-made", protein-based, outer membrane vesicle vaccines against meningococcal disease. , 2005, Vaccine.
[50] Harry L. T. Mobley,et al. Pathogenic Escherichia coli , 2004, Nature Reviews Microbiology.
[51] A. Krogh,et al. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. , 2001, Journal of molecular biology.
[52] B. Wanner,et al. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Venter,et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. , 2000, Science.
[54] T. N. Bhat,et al. The Protein Data Bank , 2000, Nucleic Acids Res..
[55] D. Zurakowski,et al. A statistically defined endpoint titer determination method for immunoassays. , 1998, Journal of immunological methods.
[56] R. Lloubès,et al. Escherichia coli tol-pal Mutants Form Outer Membrane Vesicles , 1998, Journal of bacteriology.
[57] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.